Lee S. Rosen

16.6k citations
122 papers · 12.8k · 5 hit papers · h-index 51

Impact in

  • Oncology top 0.2%
    • Bone health and treatments
    • Colorectal Cancer Treatments and Studies
    • Cancer Diagnosis and Treatment
    • Cancer Treatment and Pharmacology
  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Lee S. Rosen

118 papers receiving 12.2k citations

Lee S. Rosen's Hit Papers

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors 2016 · 622 citations
6220+8+17Years since publication50010001.5k2.0k2.5k

Peers

Lee S. Rosen
Comparison fields: 5 of 131
  • Oncology 7.3k
  • Hepatology 897
  • Pulmonary and Respiratory Medicine 3.0k
  • Orthopedics and Sports Medicine 599
  • Hematology 750
Replace Maciej Jerzy Krzakowski with:
Maciej Jerzy Krzakowski Poland
Robert W. Ross United States
Vera Hirsh Canada
Shunji Takahashi Japan
Sandy Srinivas United States
Jayesh Desai Australia
Steven R. Alberts United States
Marcella M. Johnson United States
Kristina M. Gregory United States
Saby George United States
Lee S. Rosen relative to Maciej Jerzy Krzakowski Poland Maciej Jerzy Krzakowski's profile →
Citations per field
00.5×2×3.0×
Maciej Jerzy Krzakowski · 1×
Citations per year

Countries citing papers authored by Lee S. Rosen

Since Specialization
Citations

This map shows the geographic impact of Lee S. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee S. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee S. Rosen more than expected).

Fields of papers citing papers by Lee S. Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee S. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee S. Rosen. The network helps show where Lee S. Rosen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lee S. Rosen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lee S. Rosen Line = papers co-authored together Lee S. Rosen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Hit paper breakdown →
20002540
2
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Hit paper breakdown →
2002749
3
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma
Hit paper breakdown →
2003707
4
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
Hit paper breakdown →
2016622
5 2003609
6 2004555
7
Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
Hit paper breakdown →
2008540
8 2001433
9 2009410
10 2003265
11 2002220
12 2009207
13 2007178
14 2007165
15 2015165
16 2012156
17 2002142
18 2012134
19 2007133
20 2003128

About Lee S. Rosen

Lee S. Rosen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Hematology, having authored 122 papers that have together received 12.8k indexed citations. Recurring topics across this work include Bone health and treatments (15 papers), Colorectal Cancer Treatments and Studies (15 papers), Angiogenesis and VEGF in Cancer (13 papers), Cancer Treatment and Pharmacology (11 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Medical Imaging and Pathology Studies (6 papers). The work is most often cited by research in Oncology (7.3k citations), Hepatology (897 citations), Pulmonary and Respiratory Medicine (3.0k citations), Orthopedics and Sports Medicine (599 citations) and Hematology (750 citations). Lee S. Rosen has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John J. Seaman, David Gordon, Leonard B. Saltz, Dirk J. Reitsma, Malcolm J. Moore, Louis Fehrenbacher, Gary L. Elfring, Stephen P. Ackland, Nicoletta Pirotta and John Vernon Cox. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact